Hamada Y, Yuki K, Okazaki M, Fujitani W, Matsumoto T, Hashida MK, et al
10.3389/fphys.2017.00350 166
Listen Now Upcoming Events July 2026 Optimizing GU Care: The APP Role in Multidisciplinary Collaboration July 2026 Science & Quality Fellow Program Application Deadline August 2026 AUA2027 Abstract Submissions Open August 2026 Fundamentals in Urology, Hands-on Skills Training (2026) Latest from the Journals UPJ | July 2026 First-In-Human Assessment of the UroActive Electronic Artificial Urinary Sphincter for Treating Male Patients with Stress Urinary Incontinence To evaluate the feasibility, safety, and efficacy during the first year of use of the UroActive device in male patients with stress urinary incontinence
Table 3 Comparison of glycolysis, OXPHOS, fatty acid oxidation, and glutaminolysis metabolic pathways in different cells/samples between healthy and diseased states in COPD
Recommended injection sites Three areas are standard for subcutaneous semaglutide injection: Abdomen: The preferred site for most individuals
Adems, los suplementos o frmacos sistmicos no estn exentos de efectos adversos
